Ability of the new AT receptor blocker azilsartan to block angiotensin II-induced AT receptor activation after wash-out
Introduction: The recently approved angiotensin II (Ang II) type 1 (AT 1 ) receptor blocker (ARB) azilsartan strongly reduces blood pressure (BP) in patients with hypertension. We previously reported that azilsartan showed unique binding behavior to the AT 1 receptor because of its 5-oxo-1,2,4-oxadi...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2014-03-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/1470320313482170 |